Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Which statement best describes how risk calculators and risk-enhancing factors are used in primary prevention?

In primary prevention, you use a risk calculator to estimate a patient’s chance of ASCVD events over a set period, and that numeric risk helps decide whether to start statin therapy and at what intensity. But numbers by themselves aren’t the whole story. Risk-enhancing factors provide additional context that can shift the decision when the calculated risk sits near a treatment threshold or when age or other factors might cause underestimation. These factors include things like a family history of premature ASCVD, certain lipid abnormalities beyond the standard panel, high-sensitivity C-reactive protein, metabolic syndrome, CKD, inflammatory or autoimmune conditions, and other considerations that raise or refine risk. By combining the calculated risk with these enhancers, clinicians tailor the plan for primary prevention rather than relying on a single score or on lipid testing alone. It’s not about replacing LDL-C testing or about applying only after age 75; it’s about using risk estimates plus risk-enhancing factors to guide statin therapy decisions.

In primary prevention, you use a risk calculator to estimate a patient’s chance of ASCVD events over a set period, and that numeric risk helps decide whether to start statin therapy and at what intensity. But numbers by themselves aren’t the whole story. Risk-enhancing factors provide additional context that can shift the decision when the calculated risk sits near a treatment threshold or when age or other factors might cause underestimation. These factors include things like a family history of premature ASCVD, certain lipid abnormalities beyond the standard panel, high-sensitivity C-reactive protein, metabolic syndrome, CKD, inflammatory or autoimmune conditions, and other considerations that raise or refine risk. By combining the calculated risk with these enhancers, clinicians tailor the plan for primary prevention rather than relying on a single score or on lipid testing alone. It’s not about replacing LDL-C testing or about applying only after age 75; it’s about using risk estimates plus risk-enhancing factors to guide statin therapy decisions.